Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesWork In Process
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

CV Sciences (CVSI) Receivables (2016 - 2025)

CV Sciences (CVSI) has disclosed Receivables for 13 consecutive years, with $402000.0 as the latest value for Q4 2025.

  • Quarterly Receivables fell 22.99% to $402000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $402000.0 through Dec 2025, down 22.99% year-over-year, with the annual reading at $402000.0 for FY2025, 22.99% down from the prior year.
  • Receivables hit $402000.0 in Q4 2025 for CV Sciences, down from $405000.0 in the prior quarter.
  • In the past five years, Receivables ranged from a high of $8.2 million in Q3 2021 to a low of $402000.0 in Q4 2025.
  • Historically, Receivables has averaged $3.3 million across 5 years, with a median of $652500.0 in 2023.
  • Biggest five-year swings in Receivables: surged 206.11% in 2022 and later tumbled 93.99% in 2023.
  • Year by year, Receivables stood at $2.3 million in 2021, then soared by 206.11% to $7.2 million in 2022, then crashed by 93.99% to $431000.0 in 2023, then grew by 21.11% to $522000.0 in 2024, then decreased by 22.99% to $402000.0 in 2025.
  • Business Quant data shows Receivables for CVSI at $402000.0 in Q4 2025, $405000.0 in Q3 2025, and $545000.0 in Q2 2025.